Pullulan-based dissolving microneedle arrays for enhanced transdermal delivery of small and large biomolecules

One specific technological advance in transdermal drug delivery is the development of dissolving microneedles (DMNs), which efficiently deliver therapeutics through a rapid dissolution of polymers after penetration into the skin. However, there is a limited range of water soluble, biodegradable polymers that can be used to manufacture DMN. Here, we report for the first time, the preparation and characterisation of a DMN system from the carbohydrate biopolymer, pullulan (PL). PL gels, of varying concentration, were studied for viscosity, film formation properties, and subsequently, microneedle formation. Model molecules and protein/peptide were loaded into PL DMN and characterised. The stability of model biomolecules, such as FITC-BSA and insulin, following DMN manufacture were assessed using circular dichroism. Ex-vivo porcine skin permeation studies using Franz diffusion cell apparatus for Flu-Na and FITC-BSA loaded PL-DMN were conducted. This study demonstrates that PL DMNs may serve as a promising tool for efficient transdermal drug delivery.

[1]  Ryan F. Donnelly,et al.  Design and physicochemical characterisation of novel dissolving polymeric microneedle arrays for transdermal delivery of high dose, low molecular weight drugs , 2014, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Conor O'Mahony,et al.  Processing difficulties and instability of carbohydrate microneedle arrays , 2009, Drug development and industrial pharmacy.

[3]  Thakur Raghu Raj Singh,et al.  Hydrogel-Forming Microneedle Arrays for Enhanced Transdermal Drug Delivery , 2012, Advanced functional materials.

[4]  M. Garland,et al.  Laser-Engineered Dissolving Microneedle Arrays for Transdermal Macromolecular Drug Delivery , 2011, Pharmaceutical Research.

[5]  Ryan F. Donnelly,et al.  Innovative Strategies for Enhancing Topical and Transdermal Drug Delivery , 2007 .

[6]  T. Kimoto,et al.  Safety studies of a novel starch, pullulan: chronic toxicity in rats and bacterial mutagenicity. , 1997, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  J. Kennedy,et al.  Pullulan: A novel molecule for biomedical applications. , 2017, Carbohydrate polymers.

[8]  Maelíosa T. C. McCrudden,et al.  Transdermal delivery of gentamicin using dissolving microneedle arrays for potential treatment of neonatal sepsis , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[9]  J. Murphy,et al.  Pullulan: a new cytoadhesive for cell-mediated cartilage repair , 2015, Stem Cell Research & Therapy.

[10]  Thakur Raghu Raj Singh,et al.  Optical coherence tomography is a valuable tool in the study of the effects of microneedle geometry on skin penetration characteristics and in-skin dissolution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Eneko Larrañeta,et al.  Novel nanosuspension‐based dissolving microneedle arrays for transdermal delivery of a hydrophobic drug , 2018, Journal of interdisciplinary nanomedicine.

[12]  Shashank Jain,et al.  Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application. , 2017, Journal of pharmaceutical sciences.

[13]  A. Grigoras Drug delivery systems using pullulan, a biocompatible polysaccharide produced by fungal fermentation of starch , 2019, Environmental Chemistry Letters.

[14]  Wim Jiskoot,et al.  IgG-loaded hyaluronan-based dissolving microneedles for intradermal protein delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[15]  Jung-Hwan Park,et al.  Dissolving microneedles for transdermal drug delivery. , 2008, Biomaterials.

[16]  Ryan F. Donnelly,et al.  A proposed model membrane and test method for microneedle insertion studies , 2014, International journal of pharmaceutics.

[17]  C. Hughes,et al.  Design of a Dissolving Microneedle Platform for Transdermal Delivery of a Fixed-Dose Combination of Cardiovascular Drugs. , 2015, Journal of pharmaceutical sciences.

[18]  Mei-Chin Chen,et al.  Dissolving polymer microneedle patches for rapid and efficient transdermal delivery of insulin to diabetic rats. , 2013, Acta biomaterialia.

[19]  Ryan F. Donnelly,et al.  Novel bilayer dissolving microneedle arrays with concentrated PLGA nano‐microparticles for targeted intradermal delivery: Proof of concept , 2017, Journal of controlled release : official journal of the Controlled Release Society.

[20]  Guohua Jiang,et al.  Separable Microneedles for Near-Infrared Light-Triggered Transdermal Delivery of Metformin in Diabetic Rats. , 2018, ACS biomaterials science & engineering.

[21]  Keizo Fukushima,et al.  Two-layered dissolving microneedles formulated with intermediate-acting insulin. , 2012, International journal of pharmaceutics.

[22]  H. McCarthy,et al.  Rapidly dissolving polymeric microneedles for minimally invasive intraocular drug delivery , 2016, Drug Delivery and Translational Research.

[23]  Sanjay Gupta,et al.  Self-assembled nanocomplexes of anionic pullulan and polyallylamine for DNA and pH-sensitive intracellular drug delivery , 2014, Journal of Nanoparticle Research.

[24]  P. Vavia,et al.  Effect of permeation enhancers on dynamic mechanical properties of acrylate pressure sensitive adhesives. , 2013, International journal of pharmaceutics.

[25]  Yingfu Li,et al.  Simple and ultrastable all-inclusive pullulan tablets for challenging bioassays† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c5sc04184h , 2016, Chemical science.

[26]  Maelíosa T. C. McCrudden,et al.  Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo , 2017, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[27]  Chenjie Xu,et al.  Recent advances in the design of polymeric microneedles for transdermal drug delivery and biosensing. , 2017, Lab on a chip.

[28]  Guohua Jiang,et al.  Microneedles Integrated with ZnO Quantum-Dot-Capped Mesoporous Bioactive Glasses for Glucose-Mediated Insulin Delivery. , 2018, ACS biomaterials science & engineering.

[29]  Michel Cormier,et al.  Microneedle-based vaccines. , 2009, Current topics in microbiology and immunology.

[30]  Ryan F. Donnelly,et al.  Microneedle characterisation: the need for universal acceptance criteria and GMP specifications when moving towards commercialisation , 2015, Drug Delivery and Translational Research.

[31]  Mark R Prausnitz,et al.  Dissolving microneedle patch for transdermal delivery of human growth hormone. , 2011, Small.

[32]  Eneko Larrañeta,et al.  Nanosuspension-Based Dissolving Microneedle Arrays for Intradermal Delivery of Curcumin , 2019, Pharmaceutics.

[33]  R. Donnelly,et al.  Microneedle technology , 2021, Drug Delivery Devices and Therapeutic Systems.

[34]  H. Maibach,et al.  The Pig as an Experimental Animal Model of Percutaneous Permeation in Man: Qualitative and Quantitative Observations – An Overview , 2000, Skin Pharmacology and Physiology.

[35]  W. Jiskoot,et al.  Impact-Insertion Applicator Improves Reliability of Skin Penetration by Solid Microneedle Arrays , 2014, The AAPS Journal.